# Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease

> **NCT00156611** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University Hospital Tuebingen** · enrollment: 420 (—)

## Conditions studied

- Arterial Occlusive Diseases

## Interventions

- **PROCEDURE:** Balloon Angioplasty
- **DRUG:** ReoPro

## Key facts

- **NCT ID:** NCT00156611
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2009-12
- **Target enrollment:** 420 (—)
- **Last updated:** 2006-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156611, "Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00156611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*